Calculating Peptide Stock Solution Concentrations for Assays

A concentration-response curve is only as good as the concentration axis. For peptides, that axis is surprisingly easy to get wrong: the weighed powder is not all peptide, suppliers quote molecular weights in different ways, and dilute solutions lose material to tube walls. This guide sets out the arithmetic for calculating peptide stock solution concentrations for in-vitro assays, from grams to molarity, with a worked example using the tripeptide KPV, and shows how to check the calculated value experimentally. Everything here concerns stock solutions and assay concentrations in the laboratory.

The core equation

Molar concentration is moles of solute divided by litres of solution:

C (mol/L) = m (g) / [MW (g/mol) x V (L)]

Rearranged, the volume of solvent needed to reach a target concentration is:

V (L) = m (g) / [MW (g/mol) x C (mol/L)]

Two inputs cause most of the errors: the mass m and the molecular weight MW.

Getting the mass right: net peptide content

A lyophilized peptide is a salt with bound water. The mass of actual peptide is the gross mass multiplied by the net peptide content (NPC), and, if you want only the intact target sequence, by the HPLC purity as well:

m(target) = m(gross) x NPC x purity

Net peptide content is usually determined by amino acid analysis [4], and it is distinct from purity, as explained in net peptide content vs HPLC purity. Whether to apply the purity factor depends on convention; many labs correct for content but not purity and report that choice in their methods.

Getting the molecular weight right

Check what the stated molecular weight refers to. The usual convention is to calculate molarity from the free-base (or free-acid) molecular weight of the peptide and to account for counterions through net peptide content. If a supplier gives the molecular weight of the salt form instead, do not apply an NPC correction for counterions as well, or the correction is counted twice. Also confirm the termini: an amidated C-terminus is about 1 Da lighter than the free acid, and N-terminal acetylation adds about 42 Da.

Worked example: a 10 mM KPV stock

KPV is the tripeptide Lys-Pro-Val, the C-terminal fragment of alpha-MSH. As the free acid its molecular formula is C16H30N4O4 and its average molecular weight is about 342.4 g/mol. Suppose a vial contains 5.00 mg of powder, and the certificate reports a net peptide content of 80%.

Step	Calculation	Value
Net peptide mass	5.00 mg x 0.80	4.00 mg
Moles of peptide	4.00 x 10^-3 g / 342.4 g/mol	11.68 umol
Volume for 10.0 mM	11.68 umol / 10.0 mmol/L	1.168 mL

Had the full 5.00 mg been treated as peptide, the calculated volume would have been 1.460 mL, and the true concentration of that stock would have been 11.68 umol / 1.460 mL = 8.0 mM, a 20% shortfall that would shift every point on a downstream curve.

A useful cross-check: 1 mg/mL of KPV free peptide is 1 / 342.4 = 2.92 mM.

Common unit slips

Most calculation errors are unit errors rather than conceptual ones. Three recur often enough to check every time: confusing ug/mL with uM (for KPV, 1 ug/mL is about 2.9 uM, but for a 3 kDa peptide it is about 0.33 uM); forgetting that a 1:1,000 dilution of a 10 mM stock gives 10 uM, not 1 uM; and quoting a concentration in the stock tube when the relevant figure is the final concentration in the well after all additions. Writing units beside every number in the lab notebook catches most of them.

Designing the dilution series

From a 10 mM stock, working concentrations in the micromolar and nanomolar range are made by dilution, using C1V1 = C2V2.

• Avoid tiny volumes. Pipetting 1 uL into 999 uL is imprecise. Instead, make an intermediate: 10 uL of 10 mM stock into 990 uL gives 100 uM; then 100 uL of that into 900 uL gives 10 uM.
• Use a consistent diluent. Diluting in the assay buffer or medium keeps the solvent composition constant across the series; keep any co-solvent (DMSO, acid) at the same final percentage in every well, including vehicle controls.
• Serial dilutions compound errors. A 1:3 or 1:10 series is convenient, but each transfer adds pipetting error. Change tips between steps and mix thoroughly.
• Mind surface losses at low concentration. A study of eight endocrine peptides found large differences in the fraction that stayed in solution depending on tube material, with siliconization making losses worse and 1% BSA reducing them [3]. For nanomolar solutions, use low-binding tubes, add carrier protein if the assay allows, and prepare the final dilutions close to use.

Choosing the solvent

The solvent must dissolve the peptide completely and be compatible with the assay. Bacteriostatic water, which contains 0.9% benzyl alcohol, is convenient for stocks that will be sampled repeatedly, but the preservative is carried into every dilution, so its final concentration and compatibility with cell-based readouts should be considered. For single-use aliquots, sterile water or buffer is often preferred. KPV is short and charged and dissolves readily in water. Our comparison of reconstitution solvents for peptide research covers the alternatives.

Counterions also travel into the assay. Trifluoroacetate has been reported to reduce proliferation in osteoblast cultures at 10 to 100 nM [5], so for sensitive cell-based work the salt form is worth noting when converting stock concentration into well concentration.

Verifying the concentration

Calculated concentrations are estimates; measured ones are better.

• Absorbance at 280 nm. For sequences containing Trp or Tyr, the molar absorption coefficient can be predicted from the sequence, using values of about 5,500 per Trp, 1,490 per Tyr and 125 per cystine (M^-1 cm^-1) [1]. Concentration then follows from the Beer-Lambert law.
• Absorbance at 205 nm. KPV has no Trp or Tyr, so A280 is useless. A method predicting molar absorptivity at 205 nm directly from sequence, validated for proteins and peptides lacking aromatic residues, is an alternative, though buffer components that absorb in the far UV must be avoided [2].
• Amino acid analysis. The most direct measurement of peptide quantity in a solution, and the reference when other methods disagree [4].

Recording the measured concentration alongside the calculated one, and the lot's NPC and purity from the certificate on our lab reports page, makes the calculation auditable.

Key takeaways

• Molarity equals mass divided by molecular weight and volume; errors come mainly from the mass and MW inputs.
• Multiply gross mass by net peptide content (and optionally purity) before calculating moles.
• Use the free-peptide molecular weight with an NPC correction, or the salt MW without one, never both.
• Build dilution series through intermediates, keep solvent composition constant and watch surface losses at low concentration.
• Verify stocks by A280 (Trp/Tyr peptides), A205 (non-aromatic peptides) or amino acid analysis.

This article summarizes published research for informational purposes. All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption.

References

1. Pace CN, Vajdos F, Fee L, et al. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 1995;4(11):2411-2423. PubMed
2. Anthis NJ, Clore GM. Sequence-specific determination of protein and peptide concentrations by absorbance at 205 nm. Protein Sci. 2013;22(6):851-858. PubMed
3. Goebel-Stengel M, Stengel A, Taché Y, et al. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. PubMed
4. Rutherfurd SM, Gilani GS. Amino acid analysis. Curr Protoc Protein Sci. 2009;Chapter 11:Unit 11.9. PubMed
5. Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277(5):E779-E783. PubMed